Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06123026

Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion

Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion: a Randomized Controlled Trial

Sponsor: Northwestern University

Conditions Lactation Suppressed Second Trimester Abortion

Updated 5 times since 2023 Last updated: May 28, 2024 Started: Dec 18, 2023 Primary completion: Jun 30, 2024 Completion: Jun 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06123026, this PHASE4 trial focuses on Lactation Suppressed and Second Trimester Abortion and remains actively recruiting participants. Sponsored by Northwestern University, it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Jun 2024 — Jul 2024 [monthly]

Recruiting PHASE4
Apr 2024 — Jun 2024 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Dec 2023 — Apr 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Northwestern University

Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States